Unlike other Israeli universities it exclusively offers postgraduate-only degrees in the natural and exact sciences.

Before he became President of Israel in February 1949, Weizmann conducted his research in organic chemistry at its laboratories.

[9] By 2013 the institute was earning between $50 and $100 million in royalties annually on marketed drugs including Copaxone, Rebif, and Erbitux.

and Ph.D. degrees in mathematics, computer science, physics, chemistry, biochemistry, and biology, as well as several interdisciplinary programs.

[18] The nonscientists Abba Eban and Meyer Weisgal were assisted by scientific directors, as was Weizmann himself owing to his duties as the first president of Israel.